March 2021 – CCFI /Région Auvergne Rhône-Alpes
Alma Bio Therapeutics presented in the biotech session of the special webinar “Bouncing back from the crisis. How to re-establish partnerships between Israel and the Auvergne Rhône-Alpes region”.
4th Antigen Specific Immune Tolerance event
January 2021 – Alma Bio Therapeutics attended the 4th Antigen Specific Immune Tolerance digital event.
Prof. Francisco Javier Quintana joins Alma’s scientific advisory board
September 2020 - Prof. Francisco Javier Quintana of Brigham and Women’s Hospital Harvard Medical School, a world-renowned expert in immune regulation and tolerance, joins Alma’s scientific advisory board.
French PGE
July 2020 - Alma Bio Therapeutics was among the recipients of PGE, the French government state guaranteed loan.
BioEurope Spring
March 2020 - Alma Bio Therapeutics participated at Digital BioEurope Spring
RESI Partnering Event
March 2020 - Alma Bio Theraeutics presented at the RESI Digital partnering event
Health Investor Day
Dr Binah Baum, Alma Bio Therapeutics CEO, was at the Health Investor Day in Paris on June 24th-25th, 2019.